kringle-pharmaCo., Ltd.

COMPANY

Corporate information

COMPANY PROFILE

Company Profile

Company Name
Kringle Pharma, Inc.
Established
December 21, 2001
Capital
50 million JPY (as of July 13, 2021)
Company Mission
We will contribute to our society and global health by research,
development and commercialization of innovative medicines for patients suffering from incurable diseases.
Main Project
Research & development of HGF (pharmaceuticals for regenerative medicine)

FEATURE

Our features

What HGF can do:

  • to regenerate tissues and organs
  • To treat incurable diseases

What kringle Pharma is aiming for:

  • To commercialize HGF medicine
  • To creat new values for the well-being of all people

ACCESS

access

Street address
207 Saito Bio Incubator 7-7-15 Saitoasagi, Ibaraki, OSAKA 567-0085, JAPAN

When using public transportation
Osaka Monorail Saito Line (International Culture Park City Monorail Line) Get off at Saito Nishi Station, about 8 minutes on foot
The time required: About 17 minutes from Senri-Chuo Station
※The time required does not include the transfer time at the Expo Memorial Park station.
※During morning and evening rush hours, direct driving will be carried out between Senri-Chuo and Saito-Nishi.